Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1369-1370, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37684530
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Int J Clin Oncol
Year:
2023
Document type:
Article